Stockreport

Y-mAbs Therapeutics, Inc.'s (NASDAQ:YMAB) latest 13% decline adds to one-year losses, institutional investors may consider drastic measures [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF The top 8 shareholders own 53% of the company Insiders have been selling lately We've discovered 3 warning signs about Y-mAbs Therapeutics. View them for free A l [Read more]